The effects of GLP-1sreducing hunger, slowing stomach emptying, and improving insulin sensitivity can translate into multiple benefits for women going through menopause, says Dr. Hes.
Improving Insulin Sensitivity and Blood Sugar Control: As mentioned, menopausal women are at higher risk for insulin resistance. By stimulating glucose-dependent insulin release and suppressing glucagon, GLP-1 agonists help improve insulin sensitivity and stabilize blood sugar levels.
GLP-1 can help with menopause belly by reducing visceral fat, the deep abdominal fat linked to estrogen decline which can increase risk of chronic disease. This occurs by helping to reduce insulin resistance along with overall calorie intake (4).
Moving forward, it's essential to keep these visual contexts in mind when discussing Glp-1 And Insulin Resistance In Menopausal Women.
Interest in GLP1 therapy during menopause is growing, as clinicians explore how incretins can support cardiovascular and metabolic health in midlife women. This article explores the role of GLP1 therapy in midlife women, emphasizing patient selection, counseling strategies, and coordinated care that bridges metabolic and hormonal needs.
Send us Fan Mail In this episode, Dr. Brittany Schamerhorn discusses the role of GLP-1 receptor agonists in women's health, particularly focusing on their applications in managing diabetes, obesity, and conditions like PCOS and menopause. This conversation also highlights: Risks and benefits associated with GLP-1s The complexities of managing medications and the importance of understanding ...
